Concerns and anxieties about fertility treatments can be difficult to discuss with others, and it may take time to find the necessary information. Pass Create Co., Ltd. (Headquarters: Shinjuku-ku, Tokyo, Representative Director: Takaaki Iihara) will be displaying in-train window advertisements for the fertility timing method kit "meeta Syringe" on four Tokyo Metropolitan Subway lines (Oedo Line, Mita Line, Shinjuku Line, Asakusa Line) operated by the Tokyo Metropolitan Government Bureau of Transportation, from July 1 to July 31, 2026, as an opportunity to learn about fertility options in daily life. Through these advertisements on the four Tokyo Metropolitan Subway lines, which are used by approximately 2.64 million people daily, we aim to deliver options to those who need information about fertility treatments and to broaden opportunities for society as a whole to naturally encounter discussions about fertility. Background Declining birthrates have been a long-standing social issue discussed in Japan. According to the Vital Statistics of Japan from the Ministry of Health, Labour and Welfare, there is a continuing downward trend in the number of births and the total fertility rate nationwide. On the other hand, fertility concerns and anxieties are often difficult to discuss with others, making it a topic where individuals tend to bear the burden of information gathering and considering options. We believe that establishing an environment where information on diverse options is accessible from the pre-conception stage will become increasingly important in the future. Pass Create Co., Ltd. is working to expand opportunities to easily access information related to fertility treatments by increasing awareness of the fertility timing method kit "meeta Syringe." Previously, in-train advertisements were conducted on the "Nagoya Municipal Subway Higashiyama Line in December 2025," "Fukuoka City Subway Airport Line, Hakozaki Line, and Nanakuma Line in January 2026," and "Sen